Literature DB >> 6418190

A clinical trial of alfentanil as an adjuvant for short anaesthetic procedures.

C J Hull, L Jacobson.   

Abstract

Alfentanil 700 micrograms and fentanyl 100 micrograms were compared as anaesthetic adjuvants in 90 patients undergoing short duration gynaecological procedures. The results show that, at the chosen dose ratio, alfentanil causes a higher frequency of post-induction apnoea, but thereafter the respiratory effects of the two drugs were comparable. No differences in incremental requirements or evoked movements were found. Among patients who had been given ergometrine, the alfentanil group suffered a greater frequency of nausea and vomiting in the period immediately after operation. It is concluded that in single i.v. doses, alfentanil 700 micrograms is more potent than fentanyl 100 micrograms. Moreover, the results suggest that, unlike fentanyl, this very short acting agent would be used to greater effect if given in divided doses during surgery.

Entities:  

Keywords:  Anesthesia--administraction and dosage; Anesthesia--side effects; Comparative Studies; Data Analysis; Double-blind Studies; Drugs; Epidemiologic Methods; Gynecologic Surgery; Research Methodology; Studies; Surgery; Treatment; Urogenital Surgery

Mesh:

Substances:

Year:  1983        PMID: 6418190

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Recovery after anaesthesia with alfentanil or halothane.

Authors:  D P Cartwright
Journal:  Can Anaesth Soc J       Date:  1985-09

2.  Alfentanil as an adjunct to thiopentone and nitrous oxide in short surgical procedures.

Authors:  J P Dechène
Journal:  Can Anaesth Soc J       Date:  1985-07

3.  Double blind comparison of alfentanil N2O and fentanyl N2O for outpatient surgical procedures.

Authors:  A B Enright; J B Parker
Journal:  Can J Anaesth       Date:  1988-09       Impact factor: 5.063

4.  Use of alfentanil in short anaesthetic procedures.

Authors:  K M Collins; O M Plantevin
Journal:  J R Soc Med       Date:  1985-06       Impact factor: 5.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.